OPEN END TURBO CALL WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 11:06:56 14/06/2024 pm IST | ||
| 1.41 EUR | +0.71% |
|
| Current month | -2.76% | ||
| 1 month | -5.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 1.41 | +0.71% |
| 13/24/13 | 1.4 | -0.71% |
| 12/24/12 | 1.41 | -1.40% |
| 11/24/11 | 1.43 | -1.38% |
| 10/24/10 | 1.45 | -2.03% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 11:06 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH1TAN |
| ISIN | DE000UH1TAN7 |
| Date issued | 03/09/2021 |
| Strike | 147.5 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.7 € |
|---|---|
| Lowest since issue | 0.56 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
